Skip to main content
. 2020 May 27;13:1756284820923922. doi: 10.1177/1756284820923922

Table 2.

Serum 25(OH)D3 levels and plasma inflammatory marker levels in colorectal cancer patients at diagnosis and several time points after diagnosis.

n 25(OH)D3 n IL10
(pg/ml)
n IL8 (pg/ml) n IL6 (pg/ml) n TNFα (pg/ml) n hsCRP**
(μg/ml)
n Inflammatory z-score*
At diagnosis 781 53.9
(40.8–70.2)
731 0.2
(0.2–0.4)
769 5.8
(4.3–8.2)
767 1.0
(0.7–1.7)
769 2.1
(1.7–2.6)
686 2.5
(1.1–6.0)
643 –0.5
(–2.3–1.8)
Six months after diagnosis 641 50.9
(37.2–69.7)
593 0.3
(0.2–0.5)
633 5.1
(4.0–6.8)
632 1.0
(0.7–1.8)
636 2.4
(2.0–3.0)
568 1.8
(0.9–4.1)
514 –0.5
(–2.4–1.6)
One year after diagnosis 294 52.3
(38.6–72.3)
226 0.3
(0.2–0.4)
244 4.7
(3.5–6.3)
242 0.9
(0.6–1.5)
244 2.2
(1.7–2.8)
185 1.7
(0.7–4.4)
170 –0.6
(–2.2–2.1)
Two years after diagnosis 467 64.1
(49.0–82.8)
397 0.2
(0.2–0.3)
418 5.7
(4.4–7.2)
404 0.8
(0.5–1.3)
419 1.9
(1.6–2.5)
381 0.0
(–1.8–1.6)

Values were presented as median (IQR).

*

The inflammatory z-score was calculated asz=(xμ)/σ, where x is a participant’s cytokine value at a given visit, and µ and ơ are the study population mean and standard deviation at that visit, respectively. The combined score was calculated by summing the z-scores of each inflammatory marker.

**

hsCRP was only measured at diagnosis, 6 months and 1 year after diagnosis.